Thus, taking into account the extensive list of factors that regulate the splicing of exon 10 of MAPT pre-mRNA [19], we selected and analyzed the expression of miR132-3p because some authors have reported down-regulation of this microRNA in AD progression [48,49]. This evidence concerns the gene MAPT and Alzheimer disease.